Clinical trials
Phase 1 Carcinoma, Merkel Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2010 | 2 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 10 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fate Therapeutics | 3 |
| Incyte Corporation | 3 |
| AbbVie | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Pfizer | 2 |
| TuHURA Biosciences, Inc. | 2 |
| University of Southern California | 2 |
| Arcus Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Merkel Cell | 36 |
| Melanoma | 20 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Small Cell Lung Carcinoma | 16 |
| Carcinoma, Renal Cell | 15 |
| Carcinoma, Hepatocellular | 12 |
| Carcinoma, Transitional Cell | 11 |
| Stomach Neoplasms | 11 |
| Uterine Cervical Neoplasms | 11 |
| Cutaneous Squamous Cell Carcinoma | 9 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.